We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

82 hedge funds and large institutions have $95M invested in Korro Bio in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $579K | Put options by funds: $159K

0.06% less ownership

Funds ownership: 1.09% → 1.02% (-0.06%)

7% less funds holding

Funds holding: 88 → 82 (-6)

24% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 25

30% less capital invested

Capital invested by funds: $135M → $95M (-$39.8M)

48% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 33

Holders
82
Holders Change
-6
Holders Change %
-6.82%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
17
Reduced
33
Closed
25
Calls
$579K
Puts
$159K
Net Calls
+$420K
Net Calls Change
+$86K

Top Buyers

1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.93M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$1.39M
3
GCP
GSA Capital Partners
United Kingdom
+$841K
4
BCM
Bridgeway Capital Management
Texas
+$539K
5
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$364K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$2M
2
PA
Perceptive Advisors
New York
-$1.57M
3
Stifel Financial
Stifel Financial
Missouri
-$1.42M
4
BlackRock
BlackRock
New York
-$893K
5
Two Sigma Investments
Two Sigma Investments
New York
-$893K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$16.2M -$372K -1,225 -2%
BlackRock
2
BlackRock
New York
$15.6M -$893K -2,937 -5%
Federated Hermes
3
Federated Hermes
Pennsylvania
$14.4M +$1.39M +4,571 +9%
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.47M +$119K +393 +1%
JP Morgan Chase
5
JP Morgan Chase
New York
$5.99M -$703K -2,313 -9%
N
6
Nuveen
North Carolina
$4.87M -$68.7K -226 -8%
SDIC
7
South Dakota Investment Council
South Dakota
$3.68M – – –
LOAMS
8
Lombard Odier Asset Management (Switzerland)
Switzerland
$3.63M +$364K +1,196 +9%
State Street
9
State Street
Massachusetts
$3.07M -$362K -1,190 -9%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$2.95M +$236K +778 +7%
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$1.63M +$1.93M +6,357 New
Northern Trust
12
Northern Trust
Illinois
$1.47M -$508K -1,670 -23%
Amundi
13
Amundi
France
$1.47M +$40.4K +133 +2%
GCP
14
GSA Capital Partners
United Kingdom
$1.13M +$841K +2,766 +169%
Morgan Stanley
15
Morgan Stanley
New York
$1.03M -$2M -6,568 -62%
Walleye Capital
16
Walleye Capital
New York
$750K +$159K +523 +22%
Goldman Sachs
17
Goldman Sachs
New York
$715K +$22.5K +74 +3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$600K -$5.47K -18 -0.8%
Ohio Public Employees Retirement System (OPERS)
19
Ohio Public Employees Retirement System (OPERS)
Ohio
$588K +$84.2K +277 +14%
Two Sigma Investments
20
Two Sigma Investments
New York
$537K -$893K -2,937 -58%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$504K -$510K -1,678 -46%
BCM
22
Bridgeway Capital Management
Texas
$455K +$539K +1,774 New
PPA
23
Parametric Portfolio Associates
Washington
$430K +$7.29K +24 +1%
Charles Schwab
24
Charles Schwab
California
$406K – – –
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$392K -$542K -1,783 -54%
1
2 3 4 5

KRRO Hedge Fund Activity: Q4 2021 in Review

82 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2021, worth a combined $95M — down 30% from $135M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of KRRO and 19 opened new positions — a net loss of 6 holders — while 33 trimmed existing stakes and 17 added.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $1.93M. The largest seller was Morgan Stanley, cutting an estimated $2M.

  • 82 institutional investors held Korro Bio (KRRO) as of Q4 2021, down from 88 in Q3 2021.
  • Funds reported $95M of Korro Bio stock for Q4 2021, down 30% quarter-over-quarter.
  • 19 funds opened new Korro Bio positions in Q4 2021 and 25 closed out, a net change of -6 holders.
  • The largest Korro Bio buyer in Q4 2021 was Jacobs Levy Equity Management, an estimated $1.93M added.
  • The largest Korro Bio seller in Q4 2021 was Morgan Stanley, an estimated $2M sold.

Based on aggregated 13F filings for Q4 2021.